TL;DR
A survey of 448 genetics professionals reveals a troubling lack of consensus on how to define and use race, ethnicity, and ancestry (REA) in clinical practice. Despite their critical role in precision medicine, these measures are often used inconsistently or as inaccurate proxies for one another, highlighting an urgent need for standardized clinical guidelines.
What Problem Does This Paper Address?
In the era of precision medicine, understanding a patient’s background is vital for interpreting genetic variants. For example, a rare mutation in one population might be common (and benign) in another. However, the field currently lacks a "common tongue" for diversity.
Researchers and clinicians frequently use the terms Race, Ethnicity, and Ancestry (REA), but these concepts are often conflated. Race and ethnicity are largely socio-cultural constructs reflecting environmental exposures and identity, while ancestry refers to the biological inheritance of genetic variants. When these are used interchangeably or without clear definitions, it can lead to inaccurate variant classifications, misleading clinical reports, and the exacerbation of health disparities. This paper investigates how professionals currently conceptualize and apply these measures in the real world.
Methods
The study utilized a cross-sectional survey design, developed through a partnership between two NIH-funded consortia: ClinGen and CSER.
- Survey Validation: To ensure the 121-question instrument was robust, the authors conducted 11 "cognitive interviews" with target professionals to refine the language and logic.
- Recruitment: The survey was disseminated via professional organizations (like ACMG and ASHG) and listservs, eventually employing a "snowball" approach to reach a broader network.
- Analysis: Data from 448 respondents were analyzed using descriptive statistics. The researchers used branching logic to tailor questions to specific roles (e.g., lab directors vs. genetic counselors).
Datasets
The primary "dataset" for this study is the cohort of 448 survey respondents.
- Composition: 60% were clinical professionals (geneticists, counselors, lab directors), 22% were non-clinical researchers, and the remainder were trainees or others.
- Demographics: The sample was heavily North American (93%) and majority-white (71%), which the authors note is reflective of the current demographics of the genetics profession.
Key Insights and Ideas
- The "Ancestry" Disconnect: While 66% of respondents agreed that "genetic lineage group" best describes ancestry, there is a massive gap between theory and practice. Ancestry was rated as the most important factor for variant interpretation, yet 85% of respondents reported that genetic ancestry is rarely or never actually calculated from a patient’s DNA in a clinical setting.
- Proxies by Necessity: Because genetic ancestry data is rarely available, clinicians often rely on self-reported race or medical records as a proxy. The authors warn that this is scientifically problematic, especially for individuals with multi-ancestral backgrounds.
- Heterogeneity of Thought: There was no single definition for "race" that a majority of participants agreed upon. Confidence in distinguishing between REA terms was significantly lower for "general" contexts than for "genetics-specific" contexts, suggesting that professionals feel they have a functional understanding that may not hold up under scrutiny.
- The "It Depends" Factor: For many clinical scenarios, up to a third of respondents answered "I'm not sure" or "It depends" regarding the relevance of REA, indicating a high degree of uncertainty in how to apply this data to patient care.
Key Results
- Usage: 94% of participants collect or use population identity information in their work.
- Importance: Over 55% of respondents felt REA is important for clinical variant interpretation and ordering tests.
- Clinical Motivation: 53% of professionals are more likely to discuss REA if the patient is from a racial or ethnic minority group, and 50% are motivated to do so when faced with a Variant of Uncertain Significance (VUS).
- Consensus for Change: 65% of respondents explicitly stated that new, standardized guidelines for the collection and use of REA data are necessary for the field.
Limitations and Future Work
The study’s primary limitation is its geographic and demographic bias; the respondent pool was largely white and based in the U.S., which may not capture the perspectives of professionals in more diverse global regions. Additionally, the "snowball" recruitment method makes it difficult to calculate a precise response rate.
Future Work: The authors call for a multi-disciplinary effort—involving stakeholders from clinical labs, professional organizations, and patient advocacy groups—to develop a formal framework. This framework must move beyond using race as a proxy for biology and instead promote the use of validated genetic ancestry alongside socio-cultural data to ensure precision medicine is both accurate and equitable.
Summary updated